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“Pathogenicity” refers to the capacity of a microorgan- 
ism to cause disease, whereas “virulence” denotes varia- 
tions in its magnitude.l Apart from inoculation with a 
replication incompetent virus, all isolates of human 
immunodeticiency virus type 1 (HIV-l) appear to be able 
to affect the immune systems of their human hosts; the 
intriguing differences are ones of degree. 
Virulence is clearly a property of the host-parasite 
interaction. But host fitness is exceedingly difficult to 
assess in nature. Researchers have suggested that inves- 
tigation of the extremes of this interaction - rapid pro- 
gressors versus long-term nonprogressors - might 
present the best experimental model by which to analyze 
protective and pathologic mechanisms in HIV infection2 
Wong and colleagues, in “Nonprogressors of HIV Infec- 
tion: Hong Kong Experience,” have sought to provide 
additional epidemiologic data for such studies3 
Criteria for the identification of long-term non- 
progressors vary. This author suggests a stringent one: 
evidence of HIV-l infection for 13 years or longer; no use 
of anti-retroviral drugs; no symptoms attributable to HIV; 
an absolute CD4+ T-cell count of at least 600/mm~; and 
no loss of CD4+ T cells over the previous 5 years of 
observation. By this definition, approximately 7% of 
the San Francisco City Clinic cohort and 4% of the 
Multicenter AIDS Cohort Study (MACS) could be labelled 
nonprogressors.2 
The fact that several surveys, including the report 
by Wong et al, use slightly or substantially less strict def- 
initions confounds comparisons among studies. The most 
common variations are a wider range for CD4+ T-cell 
counts (400-500/mm3) and shorter follow-up periods 
(7-10 y). The Wong et al study also failed to document 
stability of CD4 counts above 500. In a recent retro- 
spective review of 346 HIV-l positive homosexual men 
in Vancouver, no long-term nonprogressors could be iden- 
tiRed if a slope in CD4 count significantly less than zero 
was required.* Indeed, the term “nonprogressor” is prob- 
ably a misnomer; long-term delayed progression might 
be more accurate. 
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The prevalence of nonprogressors in this retrospec- 
tive survey, 8 of 58 patients, is also more than double 
that reported by others. This may relate to certain limi- 
tations in study design, not the least of which was sam- 
ple selection. Of the 106 case histories originally 
collected, 48 patients appeared lost to follow-up. The 
authors admit a bias toward hemophiliacs in a system 
where the reporting of HIV and/or AIDS is voluntary. 
Hemophiliacs, as a group, would be more likely to have 
access to continued observation than, say, an injection 
drug user. Other studies have reported nonprogressors 
not only among hemophiliacs but also among men who 
have sex with men,1’5 injection drug users, and hetero- 
sexual men and women.G 
Few immunologic, and no virologic parameters were 
investigated in the survey by Wong et al. However, other 
studies have provided clues as to the types of data impor- 
tant to analyze in the biology of nonprogession (Table 1). 
In terms of viral kinetics, genotype, and phenotype, small 
case clusters may provide leads, but these leads cannot 
necessarily be generalized. 
Ninety-nine percent of circulating virus in an HIV pos- 
itive individual appears to derive from cells having a short 
half-life, on the order of a day suggesting that repetitive 
cycles of de novo infection, virus production, and T-cell 
destruction represent the primary process, sustaining 
viremia and driving cell pathology Viral isolates from an 
Australian blood donor/recipient cohort indicated that 
deletions in one of the regulatory genes in HIV nef, might 
be critical. This hypothesis could account for the low vir- 
ulence of donor virus and its ability to remain nonvirulent 
in its new hosts.’ These findings complement data from 
early transfusion surveys that indicated that the rapidity 
with which AIDS develops in blood recipients is directly 
related to the rapidity of AIDS development in the donor.* 
This is not to imply that virology is destiny; 
sequencing of HIV isolates from unselected long-term 
Table 1. immunologic and Virologic Features of Long-Term 
Delayed Progression in HIV Infection 
Limited expression of HIV in peripheral blood and lymphoid tissues 
Nonsyncytium including, slow-replicating virus phenotype in vitro 
Intact follicular dendritic cells and germinal center architecture in 
lymph nodes 
Increased CD8+ cytolytic and noncytolytic (CAF) anti-HIV activity 
T: ,I )T ,2 cvtokine oattern of CD4+ T cells 
L&J ;pontaneous apoptosis of CD4+ T cells in vitro 
HLA phenotypes linked with nonprogression 
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nonprogressors has not revealed recurrent mutational 
motifs, in nef or any other HIV gene.6 Host factors must 
be influential. For example, productive viral infection 
may be modulated by cellular activators, including a 
variety of exogenous cofactors, from extensive ultravi- 
olet exposure to concomitant viral infections. Indeed, 
among the seven recipients in the Australian cohort, 
one patient, who was on immunosuppressive drugs for 
an autoimmune disease, rapidly developed AIDS and 
died. 
cooperation of basic researchers, clinicians, epidemlolo- 
gists, and of course, HIV positive patients. 
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